ebook Munafa Stock Market Course + Intraday & FNO calls  

       

PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

Protagonist Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Protagonist Therapeutics, Inc. PTGX

Protagonist Therapeutics, Inc. PTGX listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Protagonist Therapeutics, Inc. PTGX

Protagonist Therapeutics (PTGX) Reports Q4 Loss, Tops Revenue Estimates
Protagonist Therapeutics (PTGX) came out with a quarterly loss of [CO].77 per share versus the Zacks Consensus Estimate of a loss of [CO].79. This compares to loss of [CO].48 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 28 February 2022

Protagonist Therapeutics shares soar after FDA lifts clinical hold on its experimental cancer drug
Shares of Protagonist Therapeutics Inc. soared 87.0% in premarket trading on Monday after the company said the Food and Drug Administration had lifted a clinical hold on clinical trials of rusfertide, its experimental blood cancer treatment. The hold was
Announcement as on 11 October 2021

Announcements by Protagonist Therapeutics, Inc. first page | Prev page |

PTGX Protagonist Therapeutics, Inc. current price & indicator signals

Moving Averages for Protagonist Therapeutics, Inc.

  • 5Day Average: 95.65
  • 12Day Average: 94.65
  • 20Day Average: 91.31
  • 50Day Average: 86.08
  • 100Day Average: 85.61
  • 150Day Average: 78.32
  • 200Day Average: 72.18

PTGX Indicators & signals

Indicator MACD (12,26,9)

94.06, 90.93, 2.79
Indicator MACD is in positive zone

Indicator ADX (14)

7.1, 20.6, 17.87
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of PTGX Protagonist Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Tue Mar 2026 97.23 96.43 to 99.31 0.5% 1.1 times
16 Mon Mar 2026 96.75 92.61 to 97.08 4.75% 0.96 times
13 Fri Mar 2026 92.36 90.92 to 98.30 -3.21% 1.23 times
12 Thu Mar 2026 95.42 93.67 to 96.39 -1.1% 1.03 times
11 Wed Mar 2026 96.48 95.97 to 98.32 -0.59% 1.08 times
10 Tue Mar 2026 97.05 95.40 to 98.21 0.4% 1.18 times
09 Mon Mar 2026 96.66 91.14 to 97.54 4.96% 1 times
06 Fri Mar 2026 92.09 87.82 to 92.97 0.74% 0.79 times
05 Thu Mar 2026 91.41 90.35 to 94.54 -3.61% 0.93 times
04 Wed Mar 2026 94.83 91.03 to 95.43 3.87% 1.08 times
03 Tue Mar 2026 91.30 90.02 to 93.51 -3.12% 0.73 times
02 Mon Mar 2026 94.24 90.99 to 94.89 2.35% 1.3 times

Videos related to: PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top